Literature DB >> 15141033

The hepatitis C virus Core protein is a potent nucleic acid chaperone that directs dimerization of the viral (+) strand RNA in vitro.

Gaël Cristofari1, Roland Ivanyi-Nagy, Caroline Gabus, Steeve Boulant, Jean-Pierre Lavergne, François Penin, Jean-Luc Darlix.   

Abstract

The hepatitis C virus (HCV) is an important human pathogen causing chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. HCV is an enveloped virus with a positive-sense, single-stranded RNA genome encoding a single polyprotein that is processed to generate viral proteins. Several hundred molecules of the structural Core protein are thought to coat the genome in the viral particle, as do nucleocapsid (NC) protein molecules in Retroviruses, another class of enveloped viruses containing a positive-sense RNA genome. Retroviral NC proteins also possess nucleic acid chaperone properties that play critical roles in the structural remodelling of the genome during retrovirus replication. This analogy between HCV Core and retroviral NC proteins prompted us to investigate the putative nucleic acid chaperoning properties of the HCV Core protein. Here we report that Core protein chaperones the annealing of complementary DNA and RNA sequences and the formation of the most stable duplex by strand exchange. These results show that the HCV Core is a nucleic acid chaperone similar to retroviral NC proteins. We also find that the Core protein directs dimerization of HCV (+) RNA 3' untranslated region which is promoted by a conserved palindromic sequence possibly involved at several stages of virus replication.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15141033      PMCID: PMC419467          DOI: 10.1093/nar/gkh579

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  RNA chaperone StpA loosens interactions of the tertiary structure in the td group I intron in vivo.

Authors:  Christina Waldsich; Rupert Grossberger; Renée Schroeder
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

2.  Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

3.  In vitro asymmetric binding of the pleiotropic regulatory protein, FruR, to the ace operator controlling glyoxylate shunt enzyme synthesis.

Authors:  J C Cortay; D Nègre; M Scarabel; T M Ramseier; N B Vartak; J Reizer; M H Saier; A J Cozzone
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

4.  Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation.

Authors:  T Shimoike; S Mimori; H Tani; Y Matsuura; T Miyamura
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1.

Authors:  J L Darlix; C Gabus; M T Nugeyre; F Clavel; F Barré-Sinoussi
Journal:  J Mol Biol       Date:  1990-12-05       Impact factor: 5.469

6.  Interaction of HIV-1 reverse transcriptase with a synthetic form of its replication primer, tRNA(Lys,3).

Authors:  C Barat; S F Le Grice; J L Darlix
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

7.  Identification of the primary site of the human immunodeficiency virus type 1 RNA dimerization in vitro.

Authors:  E Skripkin; J C Paillart; R Marquet; B Ehresmann; C Ehresmann
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

8.  First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form.

Authors:  H de Rocquigny; D Ficheux; C Gabus; M C Fournié-Zaluski; J L Darlix; B P Roques
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

9.  DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  Z Tsuchihashi; P O Brown
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

10.  RNA annealing activities in HeLa nuclei.

Authors:  D S Portman; G Dreyfuss
Journal:  EMBO J       Date:  1994-01-01       Impact factor: 11.598

View more
  58 in total

1.  The hantavirus nucleocapsid protein recognizes specific features of the viral RNA panhandle and is altered in conformation upon RNA binding.

Authors:  M A Mir; A T Panganiban
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

2.  Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein.

Authors:  M A Mir; A T Panganiban
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  The bunyavirus nucleocapsid protein is an RNA chaperone: possible roles in viral RNA panhandle formation and genome replication.

Authors:  M Ayoub Mir; Antonito T Panganiban
Journal:  RNA       Date:  2006-02       Impact factor: 4.942

4.  The twenty-nine amino acid C-terminal cytoplasmic domain of poliovirus 3AB is critical for nucleic acid chaperone activity.

Authors:  Divya R Gangaramani; Elizabeth L Eden; Manthan Shah; Jeffrey J Destefano
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

5.  Hepatitis C virus genomic RNA dimerization is mediated via a kissing complex intermediate.

Authors:  Sumangala Shetty; Seungtaek Kim; Tetsuro Shimakami; Stanley M Lemon; Mihaela-Rita Mihailescu
Journal:  RNA       Date:  2010-04-01       Impact factor: 4.942

6.  Functional replacement of a domain in the rubella virus p150 replicase protein by the virus capsid protein.

Authors:  Wen-Pin Tzeng; Teryl K Frey
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

7.  Hepatitis C virus core protein is a dimeric alpha-helical protein exhibiting membrane protein features.

Authors:  Steeve Boulant; Christophe Vanbelle; Christine Ebel; François Penin; Jean-Pierre Lavergne
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Kinetic analysis of the nucleic acid chaperone activity of the hepatitis C virus core protein.

Authors:  Kamal kant Sharma; Pascal Didier; Jean Luc Darlix; Hugues de Rocquigny; Hayet Bensikaddour; Jean-Pierre Lavergne; François Pénin; Jean-Marc Lessinger; Yves Mély
Journal:  Nucleic Acids Res       Date:  2010-02-18       Impact factor: 16.971

9.  Biological autoimmunity screening in hepatitis C patients by anti-HepG2 lysate and anti-heat shock protein 70.1 autoantibodies.

Authors:  B F F Chumpitazi; L Bouillet; M-T Drouet; L Kuhn; J Garin; J-P Zarski; C Drouet
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-08-12       Impact factor: 3.267

10.  A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B.

Authors:  Lucile Warter; Lisette Cohen; Yann Benureau; Deborah Chavez; Yan Yang; Francis Bodola; Stanley M Lemon; Cinzia Traboni; Robert E Lanford; Annette Martin
Journal:  PLoS One       Date:  2009-02-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.